Sage to lay off half of workforce in cost-cutting retrenchment

Sage Therapeutics will lay off a little over half of its roughly 650-person workforce, sharply cutting back on spending in a restructuring aimed at redirecting resources toward the Cambridge, Massachusetts-based biotech's experimental treatment for depression.